BIOCON LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 306.4 INR | +5.06% |
|
+17.10% | +22.73% |
| 04-18 | India's Biocon developing its own version of Wegovy, clinical trial likely next year | RE |
| 04-18 | Biocon Signs Licensing and Supply Pact with Biomm to Commercialize Generic Ozempic in Brazil | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 326.95 | 339.00 | 326.95 |
| Spread/Res. | -6.29% | -9.62% | -6.29% |
| Spread/Supp. | +10.10% | +17.10% | +17.10% |
| Support | 278.30 | 261.65 | 261.65 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- BIOCON Stock
- Charts Biocon Limited
